Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH
Open Access
- 1 November 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 21 (1), 208-216
- https://doi.org/10.1093/ndt/gfi188
Abstract
Background. Chronic exposure to conventional peritoneal dialysis fluid (PDF) is associated with functional and structural alterations of the peritoneal membrane. The bioincompatibility of conventional PDF can be due to hypertonicity, high glucose concentration, lactate buffering system, presence of glucose degradation products (GDPs) and/or acidic pH. Although various investigators have studied the sole effects of hyperosmolarity, high glucose, GDPs and lactate buffer in experimental PD, less attention has been paid to the chronic impact of low pH in vivo. Methods. Rats received daily 10 ml of either conventional lactate-buffered PDF (pH 5.2; n = 7), a standard bicarbonate/lactate-buffered PDF with physiological pH (n = 8), bicarbonate/lactate-buffered PDF with acidic pH (adjusted to pH 5.2 with 1 N hydrochloride, n = 5), or bicarbonate/lactate buffer, without glucose, pH 7.4 (n = 7). Fluids were instilled via peritoneal catheters connected to implanted subcutaneous mini vascular access ports for 8 weeks. Control animals with or without peritoneal catheters served as control groups (n = 8/group). Various functional (2 h PET) and morphological/cellular parameters were analyzed. Results. Compared with control groups and the buffer group, conventional lactate-buffered PDF induced a number of morphological/cellular changes, including angiogenesis and fibrosis in various peritoneal tissues (all parameters PPPPConclusion. The bicarbonate/lactate-buffered PDF, acidity per se did not contribute substantially to peritoneal worsening in our in vivo model for PD, which might be explained by the buffering capacity of the peritoneum.This publication has 12 references indexed in Scilit:
- Synergistic Cytotoxicity of Acidity and 3,4‐Dideoxyglucosone‐3‐ene Under the Existence of Lactate in Peritoneal Dialysis FluidTherapeutic Apheresis and Dialysis, 2005
- Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membraneKidney International, 2004
- Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivoNephrology Dialysis Transplantation, 2003
- Glucose-mediated induction of TGF-β1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependentKidney International, 2003
- Glucose degradation products increase apoptosis of human mesothelial cellsNephrology Dialysis Transplantation, 2003
- Experimental diabetes induces functional and structural changes in the peritoneumKidney International, 2002
- 3,4-Dideoxyglucosone-3-ene (3,4-DGE): A cytotoxic glucose degradation product in fluids for peritoneal dialysisKidney International, 2002
- Induction of hyaluronan metabolism after mechanical injury of human peritoneal mesothelial cells in vitroKidney International, 2000
- Advanced glycation and lipidoxidation of the peritoneal membrane: Respective roles of serum and peritoneal fluid reactive carbonyl compoundsKidney International, 2000
- Biocompatibility and buffers: Effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell functionKidney International, 1998